GINA ROBINSON: Open Payments
NPI 1629514559 · WEDDINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 32 payments from 13 companies in 2025. Trend: 2023 $1,655 · 2024 $2,255 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $212 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Abbott Laboratories | 1 | $26 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: Wegovy, Ozempic, Saxenda, FREESTYLE LIBRE 3, Tlando, JARDIANCE, FARXIGA, AZMIRO.
Industry payments across NC — which companies pay providers there.
